Discovering biomarkers using spatial proteomics technology

We talked to Lucy Lu (left), President of SYNCELL North American operations (San Francisco, CA, USA), at last year’s meeting of the Society for Neuroscience (SfN; 12–16 November; San Diego, CA, USA). SYNCELL is a startup company working in the spatial biology field to produce an optoproteomic technology, MicroscoopTM, that can be used in biomarker discovery. Microscoop has multiple applications, from understanding the molecular basis of disease to investigating cellular processes; its ability to identify biomarkers is an essential part of disease profiling and drug development. Tell us about the poster you’re presenting at SfN. Our poster demonstrates how our...